The etiology is unknown, probably involves genetic, infectious, and immunological factors. The characteristic feature of the disease is found in the bone lesions, which typically involve the anterior chest wall and axial skeleton. Spondylodiscitis in SAPHO syndrome is sometimes difficult to distinguish from infectious spondylodiscitis. Nonsteroidal antiinflammatory drugs are usually the efficient treatment. Cases of destructive spondylitis leading to spinal cord compression are rarely reported in the literature.
CASE REPORT
A 50-year-old male, with 10 years history of palmoplantar pustulosis, presented with a six-month history of inflammatory back pain. He had no significant family history. Physical examination showed restricted back movement (Schöber test was at 1.5 cm) with tenderness over thoracolumbar spinal processes. His body temperature was 37.2° Celsius. Dermatological examination was unremarkable.
Laboratory examination revealed a slightly elevated C-reactive protein level (16 mg/L) and erythrocyte sedimentation rate (40 mm). Serum levels of calcium, albumin and phosphorus were within the normal range. Blood cell counts, liver tests, and renal function were unremarkable. Blood cultures, urinanalysis, tumor markers, and serodiagnosis for brucella were negative. Tuberculosis skin test was negative. Spine magnetic resonance imaging showed low T 1 , high T 2 signal and contrast enhancement in the T 4 /T 5 and L 3 vertebral body and in the T 4 /T 5 disk (Figure 1 ). Sacroiliac joints were normal. Computed tomography-guided biopsy of the T 4 /T 5 disc demonstrated nonspecific inflammation and culture of this specimen was negative. Computed tomography scan of the sternoclavicular joints revealed hyperostosis and erosions involving the sternum as well as medial end of clavicle (Figure 2 ). Clavicular biopsy showed irregular sclerotic trabeculae. Human leukocyte antigen B27 typing was positive.
Thus, the diagnosis of SAPHO syndrome was established. Despite the use of nonsteroidal antiinflammatory drug, the disease remained active as attested by Bath Ankylosing Spondylitis Disease Activity Index at 6.7 at three-month follow-up. Then, the patient was lost to follow-up. One year later, he presented with hypesthesia and muscle weakness of his lower limb associated with kyphotic deformity and sphincter symptoms. He was unable to walk. Magnetic resonance imaging showed a vertebral collapse associated with spinal cord compression at T 5 ( Figure 3 
DISCUSSION
Synovitis, acne, pustulosis, hyperostosis, and osteitis syndrome is a rare group of sterile, inflammatory osteoarticular disorders classically associated with skin manifestations. The skin lesions are typically palmar and plantar pustulosis and acne. 1 Bone and joint lesions including aseptic osteitis, hyperostosis, and synovitis may either precede, occur simultaneously or after the start of the skin lesions. In our patient, dermatological manifestations preceded the occurrence of bone and articular lesions. The most common site of skeletal involvement is the anterior chest wall (70-90%) followed by the spine, where abnormalities are found in approximately one-third of patients. 2 Vertebral involvement may manifest as vertebral body osteosclerosis, hyperostosis, paravertebral ossification, lesions at the discovertebral junction, and may lead to vertebral collapse as described in our patient. 2 In about 15% of cases, the enthesophytes are limited to the anterior vertebral corner. And usually, they extend to involve the adjacent vertebral endplate, the anterior vertebral cortex or the adjacent vertebral corner through the disc annulus. Involvement of at least two adjacent vertebrae is present in about 30% of cases. 3 Radiological signs of SAPHO may sometimes be difficult to differentiate from infectious spondylodiscitis and even tumors, leading to a diagnostic delay. Indeed, the intervertebral disc may be narrowed, and, in 10% of cases, magnetic resonance imaging shows high signal intensity on T 2 -weighted images and gadolinium enhancement, simulating infectious spondylodiscitis. [3] [4] [5] [6] [7] Despite the similarities of the radiological findings in inflammatory and infectious spondylodiscitis, some differences should be highlighted. As in our patient, no abscesses are observed in SAPHO syndrome. Furthermore, multiple foci of spondylodiscitis are uncommon in infection. 5 Biopsy of the disk space in patients with SAPHO syndrome reveals chronic sterile nonspecific inflammation. 6, 7 In our patient, the diagnosis of spondylodiscitis related SAPHO syndrome was established based on the medical history of palmoplantar pustulosis and computed tomography-guided biopsy which showed negative results for metastatic tumor or infection associated with hyperostosis, erosions involving sternum and medial end of clavicle and the presence of human leukocyte antigen B27. Indeed, in adults with SAPHO syndrome, prevalence of the human leukocyte antigen B27 is high and varies between 13 to 30%. 1 In our patient, the main differential diagnosis was ankylosing spondylitis. However, the medical history of palmoplantar pustulosis and the presence of hyperostosis involving sternum and medial end of clavicle were against this diagnosis. The involvement of the sternoclavicular joint is uncommon, occurring in less than 4% of patients with ankylosing spondylitis. 8 The spinal lesions in SAPHO syndrome usually have a good prognosis and rarely cause neurological deterioration. 5 In fact, they generally have an insidious onset and repeated recurrence and remission. In SAPHO syndrome, destructive lesions progress associated with marginal sclerosis explaining why destructive spondylodiscitis progresses slowly. However, if the speed of destruction by inflammation is faster than that of sclerotic reaction, the spinal structure would break. 8 We described herein a case of SAPHO syndrome complicated by severe destruction and kyphotic deformity leading to paralysis. To our knowledge, there are only seven cases of SAPHO syndrome with neurological deficit summarized in Table 1. 9-14 Surgery was performed leading to improved neurological signs.
Treatment of SAPHO syndrome is not yet well codified. It is often based on isolated cases and reports of small series of patients. It was demonstrated that the use of tumor necrosis factor inhibitors leads to favorable clinical outcomes in patients with SAPHO syndrome. 15, 16 Similarly, clinical remission was obtained under etanercept in our patient.
The diagnosis of spondylodiscitis related to SAPHO syndrome is difficult and may be misleading. Presence of tumors and infectious spondylodiscitis should be considered in all patients. Furthermore, our case is original due to the occurrence of spinal cord compression with SAPHO syndrome. This case highlights that neurological examination is compulsory during follow-up. Proper early treatment based on tumor necrosis factor-alpha blockers may prevent further neurological damage of spondylodiscitis related to SAPHO syndrome. 10 Gédouin et al. 11 Fujii et al. 12 Mulleman et al. 13 Takigawa et al. 8 Nakamura et al. 
